评估一种快速抗原检测试剂盒（Panbio™ COVID-19 Ag Rapid Test Device）作为儿科急诊的即时诊断工具用于 COVID-19 的检测。
Evaluation of a rapid antigen detection test (Panbio™ COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a pediatric emergency department.
机构信息
Pediatric Department, Hospital Clínico Universitario, Valencia, Spain.
Department of Pediatrics, University of Valencia, Valencia, Spain.
出版信息
J Med Virol. 2021 Dec;93(12):6803-6807. doi: 10.1002/jmv.27220. Epub 2021 Jul 27.
Abstract
We evaluated the Panbio™ COVID-19 Ag Rapid Test Device as a point-of-care diagnostic tool for COVID-19 in 357 patients at a pediatric emergency department. Thirty-four patients tested positive by reverse transcription polymerase chain reaction, of which 24 were positive by the antigen assay. The sensitivity and specificity of the assay were 70.5% and 100%, respectively.
摘要
我们评估了 Panbio™ COVID-19 Ag Rapid Test Device 在儿科急诊 357 名患者中的 COVID-19 即时诊断工具性能。34 名患者经逆转录聚合酶链反应检测呈阳性，其中 24 名经抗原检测呈阳性。该检测的灵敏度和特异性分别为 70.5%和 100%。
相似文献
1
Evaluation of a rapid antigen detection test (Panbio™ COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a pediatric emergency department.评估一种快速抗原检测试剂盒（Panbio™ COVID-19 Ag Rapid Test Device）作为儿科急诊的即时诊断工具用于 COVID-19 的检测。
J Med Virol. 2021 Dec;93(12):6803-6807. doi: 10.1002/jmv.27220. Epub 2021 Jul 27.
2
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres.基层医疗机构中一种用于 COVID-19 诊断的快速抗原检测试剂（Panbio™ COVID-19 Ag Rapid Test Device）的现场评估。
Clin Microbiol Infect. 2021 Mar;27(3):472.e7-472.e10. doi: 10.1016/j.cmi.2020.11.004. Epub 2020 Nov 13.
3
Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.基于化学发光酶免疫分析的高通量 SARS-CoV-2 抗原检测试剂盒用于 COVID-19 诊断的评估：VITROS® SARS-CoV-2 抗原检测试剂盒。
J Med Virol. 2021 Dec;93(12):6778-6781. doi: 10.1002/jmv.27153. Epub 2021 Aug 12.
4
Field evaluation of COVID-19 antigen tests versus RNA based detection: Potential lower sensitivity compensated by immediate results, technical simplicity, and low cost.现场评估 COVID-19 抗原检测与基于 RNA 的检测：即时结果、技术简单性和低成本弥补了潜在的低灵敏度。
J Med Virol. 2021 Jul;93(7):4405-4410. doi: 10.1002/jmv.26985. Epub 2021 Apr 8.
5
Immunochromatographic test for the detection of SARS-CoV-2 in saliva.免疫层析试验检测唾液中的 SARS-CoV-2。
J Infect Chemother. 2021 Feb;27(2):384-386. doi: 10.1016/j.jiac.2020.11.016. Epub 2020 Dec 23.
6
Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2.用于检测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的Panbio快速抗原检测对咽拭子的诊断准确性。
PLoS One. 2021 Jun 24;16(6):e0253321. doi: 10.1371/journal.pone.0253321. eCollection 2021.
7
Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.罗氏 SARS-CoV-2 快速抗原检测的临床评估。
Diagnosis (Berl). 2021 Jan 18;8(3):322-326. doi: 10.1515/dx-2020-0154. Print 2021 Aug 26.
8
Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads.新型冠状病毒抗原检测在儿科人群大规模筛查中的可行性和有效性评估及其与病毒载量动力学的相关性。
Viruses. 2021 Oct 14;13(10):2071. doi: 10.3390/v13102071.
9
Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR.即时检测点使用与 RT-qPCR 相比的 SARS-CoV-2 快速抗原检测的临床性能评估。
EBioMedicine. 2021 Jul;69:103455. doi: 10.1016/j.ebiom.2021.103455. Epub 2021 Jun 26.
10
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients.评估一种用于检测 COVID-19 患者无症状密切接触者中 SARS-CoV-2 的快速抗原检测（Panbio™ COVID-19 Ag 快速检测设备）。
Clin Microbiol Infect. 2021 Apr;27(4):636.e1-636.e4. doi: 10.1016/j.cmi.2020.12.022. Epub 2021 Jan 6.
引用本文的文献
1
Clinical Evaluation of the Healgen Rapid COVID-19 Antigen Test as a Point-of-Care Diagnostic Tool.Healgen新冠病毒快速抗原检测作为即时诊断工具的临床评估
Immun Inflamm Dis. 2025 Jul;13(7):e70228. doi: 10.1002/iid3.70228.
2
Diagnostic accuracy of Panbio™ rapid antigen test for SARS-CoV-2 in paediatric population.Panbio™ 快速抗原检测试剂盒用于儿童人群中 SARS-CoV-2 的诊断准确性。
BMC Pediatr. 2023 Aug 29;23(1):433. doi: 10.1186/s12887-023-04201-z.
3
Point-of-care PCR testing of SARS-CoV-2 in the emergency department: Influence on workflow and efficiency.急诊科即时聚合酶链反应检测 SARS-CoV-2：对工作流程和效率的影响。
PLoS One. 2023 Aug 3;18(8):e0288906. doi: 10.1371/journal.pone.0288906. eCollection 2023.
4
Should rapid antigen tests be first-line for COVID-19 testing? Results of a prospective urban cohort study.快速抗原检测是否应作为 COVID-19 检测的一线手段？一项前瞻性城市队列研究的结果。
BMC Infect Dis. 2023 Apr 18;23(1):243. doi: 10.1186/s12879-023-08171-6.
5
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing (January 2023).美国传染病学会关于 COVID-19 诊断的指南：抗原检测（2023 年 1 月）。
Clin Infect Dis. 2024 Jun 27;78(7):e350-e384. doi: 10.1093/cid/ciad032.
6
A Cross-Sectional Comparative Characterization of Hematological Changes in Patients with COVID-19 Infection, Non-COVID Influenza-like Illnesses and Healthy Controls.一项关于 COVID-19 感染、非 COVID 流感样疾病与健康对照者血液学变化的横断面对比特征研究。
Viruses. 2022 Dec 31;15(1):134. doi: 10.3390/v15010134.
7
Evaluation of the Rapid Antigen Detection Test for Diagnosing SARS-CoV-2 during the COVID-19 Pandemic: Experience from a Centralized Isolation Site in Shanghai, China.评价 COVID-19 大流行期间用于诊断 SARS-CoV-2 的快速抗原检测试验：来自中国上海集中隔离点的经验。
Microbiol Spectr. 2023 Feb 14;11(1):e0454222. doi: 10.1128/spectrum.04542-22. Epub 2023 Jan 19.
8
Clinical accuracy of SARS-CoV-2 rapid antigen testing in screening children and adolescents.严重急性呼吸综合征冠状病毒2快速抗原检测在筛查儿童和青少年中的临床准确性
J Infect. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2022.12.017. Epub 2022 Dec 21.
9
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）在急诊科的抗原检测：意大利第四波 COVID-19 期间儿科队列的数据。
Ital J Pediatr. 2022 Aug 26;48(1):155. doi: 10.1186/s13052-022-01343-1.
10
Diagnostic Performance of the Rapid Antigen Test as a Screening Tool for SARS-CoV-2 Infection in the Emergency Department.快速抗原检测作为急诊科严重急性呼吸综合征冠状病毒2感染筛查工具的诊断性能
J Pers Med. 2022 Jul 19;12(7):1172. doi: 10.3390/jpm12071172.
本文引用的文献
1
Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults.上呼吸道 SARS-CoV-2 RNA 载量在有症状和无症状儿童和成人中的变化。
Clin Microbiol Infect. 2021 Dec;27(12):1858.e1-1858.e7. doi: 10.1016/j.cmi.2021.08.001. Epub 2021 Aug 9.
2
Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as of November 20, 2020.2020 年 11 月 20 日之前已有的数据的系统荟萃分析：商业 SARS-CoV-2 快速抗原检测在疑似 COVID-19 中的真实世界临床性能。
Int J Infect Dis. 2021 Jul;108:592-602. doi: 10.1016/j.ijid.2021.05.029. Epub 2021 May 17.
3
Think of the Children: Evaluation of SARS-CoV-2 Rapid Antigen Test in Pediatric Population.为孩子们着想：儿科人群中新型冠状病毒2型快速抗原检测的评估
Pediatr Infect Dis J. 2021 May 1;40(5):385-388. doi: 10.1097/INF.0000000000003101.
4
Diagnostic Accuracy of the Panbio Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Rapid Test Compared with Reverse-Transcriptase Polymerase Chain Reaction Testing of Nasopharyngeal Samples in the Pediatric Population.儿童人群中，与鼻咽样本逆转录-聚合酶链反应检测相比，Panbio 严重急性呼吸综合征冠状病毒 2 抗原快速检测的诊断准确性。
J Pediatr. 2021 May;232:287-289.e4. doi: 10.1016/j.jpeds.2021.01.027. Epub 2021 Jan 21.
5
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres.基层医疗机构中一种用于 COVID-19 诊断的快速抗原检测试剂（Panbio™ COVID-19 Ag Rapid Test Device）的现场评估。
Clin Microbiol Infect. 2021 Mar;27(3):472.e7-472.e10. doi: 10.1016/j.cmi.2020.11.004. Epub 2020 Nov 13.
6
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19).2019年早期急性冠状病毒病（COVID-19）儿童和成人上呼吸道中的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒载量
Clin Infect Dis. 2021 Jul 1;73(1):148-150. doi: 10.1093/cid/ciaa1157.
7
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19).年龄相关的轻度至中度 2019 冠状病毒病（COVID-19）患者鼻咽严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）水平的差异。
JAMA Pediatr. 2020 Sep 1;174(9):902-903. doi: 10.1001/jamapediatrics.2020.3651.
8
Culture-Based Virus Isolation To Evaluate Potential Infectivity of Clinical Specimens Tested for COVID-19.基于培养的病毒分离法评估用于检测 COVID-19 的临床标本的潜在传染性。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01068-20.
Zotero 插件